PubMed · 1996 · 80 citations · 13 references
Life SciencesGeneticsMolecular GeneticsCytogeneticsHuman GeneticsNeurogeneticsGenetic DisordersHereditary NeuropathiesMendelian Neurological DisordersNeurogenetic DisordersPeripheral Nerve DisordersPeripheral NeuropathiesCorpus Callosum Abnormalities
Peripheral neuropathy with or without agenesis of the corpus callosum (ACCPN) is a devastating neurodegenerative disorder that is transmitted as an autosomal recessive trait. Genealogical studies in a large number of affected French Canadian individuals suggest that ACCPN results from a single founder mutation. A genomewide search using 120 microsatellite DNA markers in 14 French Canadian families allowed the mapping of the ACCPN gene to a 5-cM region on chromosome 15q13-q15 that is flanked by markers D15S1040 and D15S118. A maximum two-point LOD score of 11.1 was obtained with the marker D15S971 at a recombination fraction of 0. Haplotype analysis and linkage disequilibrium support a founder effect. These findings are the first step in the identification of the gene responsible for ACCPN, which may shed some light on the numerous conditions associated with the progressive peripheral neuropathy or agenesis of the corpus callosum.
13
Strategies for multilocus linkage analysis in humans.
G.M. Lathrop, J.-M. Lalouel, Cécile Julier et al. · Proceedings of the National Academy of Sciences · 1984 · 2.6K citations · Full text
Life Sciences, Genetics, Genomics +16
Assignment of a second Charcot-Marie-Tooth type II locus to chromosome 3q.
Jennifer M. Kwon, Jeffrey L. Elliott, Woon-Chee Yee et al. · PubMed · 1995 · 147 citations